SRPT LEGAL ALERT: Lose Money on Your Sarepta Therapeutics, Inc. Investment? Contact BFA Law by August 25 Class Action Deadline (NASDAQ:SRPT)
If you invested in Sarepta, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/sarepta-therapeutics-inc-class-action.
Investors have until August 25, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Sarepta securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Dolgicer v. Sarepta Therapeutics, Inc., et al., No. 25-cv-05317.
Why Was Sarepta Sued for Securities Fraud?
Sarepta is a biopharmaceutical company focused on developing treatments for rare diseases. Sarepta's most important product is Elevidys, a therapy for the treatment of Duchenne muscular dystrophy. As alleged, Sarepta repeatedly touted the safety profile of Elevidys and told investors that the benefits of the treatment outweighed its risks.
In truth, Elevidys causes fatal acute liver failure in some patients.
The Stock Declines as the Truth Is Revealed
On March 18, 2025, Sarepta announced that a patient that had been treated with Elevidys died after suffering acute liver failure. On this news, the price of Sarepta stock fell $27.81 per share, or over 27%, from $101.35 per share on March 17, 2025, to $73.54 per share on March 18, 2025. Nevertheless, on the same day, Sarepta assured investors that 'the benefit-risk of ELEVIDYS remains positive.'
Next, on June 15, 2025, Sarepta announced that a second patient treated with Elevidys had died from acute liver failure and that it was suspending certain shipments of Elevidys and paused dosing in an ongoing clinical trial of the treatment. On this news, the price of Sarepta stock fell $15.24 per share, or more than 42%, from $36.18 per share on June 13, 2025, to $20.94 per share on June 16, 2025.
Finally, on July 17, 2025, Sarepta revealed that a third patient treated with one of Sarepta's investigational treatments related to Elevidys had died from acute liver failure in June 2025. On this news, the price of Sarepta stock fell more than 40% on July 18, 2025.
Click here for more information: https://www.bfalaw.com/cases-investigations/sarepta-therapeutics-inc-class-action.
What Can You Do?
If you invested in Sarepta you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Submit your information by visiting:
https://www.bfalaw.com/cases-investigations/sarepta-therapeutics-inc-class-action
Or contact:
Ross Shikowitz
[email protected]
212.789.3619
Why Bleichmar Fonti & Auld LLP?
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named 'Elite Trial Lawyers' by the National Law Journal, among the top '500 Leading Plaintiff Financial Lawyers' by Lawdragon, 'Titans of the Plaintiffs' Bar' by Law360 and 'SuperLawyers' by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
https://www.bfalaw.com/cases-investigations/sarepta-therapeutics-inc-class-action
Attorney advertising. Past results do not guarantee future outcomes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
FlexGen Expands Global Battery Energy Storage Leadership with Court Approval of Powin Assets Acquisition
The purchase will reinforce FlexGen's leadership, serving an additional 14.5 plus GWh of battery energy storage system projects. DURHAM, N.C., August 06, 2025--(BUSINESS WIRE)--FlexGen Power Systems, LLC ("FlexGen"), a leading provider of battery energy storage solutions and energy management software, today announced that the U.S. Bankruptcy Court for the District of New Jersey, the Court presiding over the Chapter 11 cases of Powin, LLC and Powin affiliates, has approved FlexGen's acquisition of a substantial portion of Powin's business, advancing FlexGen's mission to future proof global grids and growing energy demand through battery energy storage. Through the acquisition, FlexGen will own all of Powin's IP, including hardware IP, software IP and information technology systems, along with a significant spare parts inventory. Upon closing of the acquisition, FlexGen will support over 25 GWh of battery energy storage systems and 200 projects across 10 countries in its portfolio. FlexGen's Remote Operations Center (ROC) will gain system visibility to ensure continuity for Powin customers, while its FlexGen HybridOS® controls software, analytics modules and lifecycle services will be made available to provide additional insights and best-in-class system availability. "This is a significant milestone, not just for FlexGen, but for the entire industry, as storage is no longer a nice-to-have, but rather, essential to meeting global energy demand and opportunities," said FlexGen CEO, Kelcy Pegler. "With this acquisition, we will continue to deliver the reliability and intelligence the grid, data centers and communities need to thrive in a world of growing energy needs." Drawing on 15 years of integration experience with over 65 configurations from 22 global vendors, FlexGen is prepared to deliver immediate continuity and support for Powin customers. With its full suite of lifecycle services and hardware-agnostic FlexGen HybridOS® software products, FlexGen meets operators where they are today while driving an AI-centric roadmap for its analytics module and sophisticated controls software. The impact is futureproofing customer investments with maximum uptime and minimal disruption. "Our top priority is customer success and delivering immediate operational stability, maximizing the value and performance of their systems. FlexGen's proven financial strength means we're a capital-light software and services partner that will remain in business to deliver on our customer promises," added Gary Cristini, FlexGen's CFO. "We thank Powin for their early-mover role in shaping the dynamic and important grid-scale battery market and honor our commitment to carry on that legacy and deliver exceptional uptime, reliability and customer success." For more information about FlexGen and this transition, visit: If you're an existing Powin customer with questions, please reach out to: PowinSupport@ About FlexGen Power Systems, LLC. FlexGen provides industry-leading software and services for deploying, managing and optimizing battery energy storage systems. FlexGen leverages decades of software, engineering, and procurement expertise to solve today's toughest energy challenges that enable the transition to a modern electric grid. FlexGen HybridOS® energy management software seamlessly integrates with any battery OEM and offers advanced analytics and AI-driven insights that allow energy storage owners to deploy diverse power market strategies and integrate various generation forms, enhancing grid stability and economic returns. Serving more than 25 GWh and over 200 energy storage systems enabled by FlexGen, we are trusted by the most technically and commercially demanding developers, utilities, government agencies, and industrial companies in the world. View source version on Contacts Media Inquiries: flexgen@ Sign in to access your portfolio
Yahoo
18 minutes ago
- Yahoo
Activist investor Starboard builds over 9% stake in Rogers
(Reuters) -Activist investor Starboard Value said on Wednesday it has built a 9.3% stake in Rogers Corp as it seeks to push for changes at the advanced materials maker. Shares of Rogers were up 10% in extended trade. However, the stock has fallen more than 30% so far this year. Rogers, which makes advanced materials used in electric and hybrid cars, automotive safety, radar systems and other industrial applications, has a market value of about $1.28 billion, according to data compiled by LSEG. Reuters reported in 2023 that the activist investor was building a sizable stake in Rogers and was seeking seats on the company's board in its push for changes. The investor said it believes shares of Rogers, at the time of purchase, were undervalued and represented an attractive investment opportunity. Starboard had previously entered into an agreement with Rogers regarding the composition of its board and other matters, it said in a regulatory filing. Following the agreement, Starboard has engaged in discussions with Rogers' management and board regarding opportunities for value creation. The Wall Street Journal reported that Starboard had built a stake of over 9% in Rogers earlier on Wednesday. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
Activist investor Starboard builds over 9% stake in Rogers, WSJ reports
(Reuters) -Activist investor Starboard Value has more than a 9% stake in Rogers Corp and plans to seek another round of changes at the engineering-materials maker to boost shares, the Wall Street Journal reported on Wednesday, citing people familiar with the matter. Rogers, which makes advanced materials used in electric and hybrid cars, automotive safety, radar systems and other industrial applications, has a market value of about $1.28 billion, according to data compiled by LSEG. Reuters reported in 2023 that the activist investor was building a sizable stake in Rogers and was seeking seats on the company's board in its push for changes. Starboard Value did not immediately respond to a Reuters request for comment. Rogers declined to comment. Shares of Rogers were up 10% in extended trade. However, the stock has fallen more than 30% so far this year. The Journal report added that Starboard's position in the company is expected to be disclosed later on Wednesday in a securities filing.
